Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis：Contezolid, Delamanid and Bedaquiline Cohort
Clinical trial NCT06081361 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06081361
- Sponsor
- Beijing Chest Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-22
- Primary completion
- 2026-10-01
- Enrollment
- 186
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.